Diagnostic value of colposcopy in patients with cytology-negative and HR-HPV-positive cervical lesions
- 23 March 2022
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 306 (4) , 1161-1169
Abstract
Purpose High-risk human papillomavirus (HR-HPV)-positive but cytology-negative cervical cancer screening results are not uncommon. This study aimed to investigate colposcopy’s accuracy and diagnostic value in patients with cytology-negative HR-HPV-positive screening results. Methods This retrospective study included patients with HR-HPV-positive cytology-negative screening results who underwent electronic colposcopy with acetic acid and multi-point cervical biopsy, HPV typing (24 HPV subtypes), and quantitative HPV detection. Results Among 229 patients, 130 had chronic cervicitis, and 99 had cervical lesions (CIN1, n = 37; CIN2/3, n = 55; invasive carcinoma, n = 7). Using colposcopy as a reference, the cervical cytology false-negative rate was 43.2% (99/229). Colposcopy was more accurate in patients with HR-HPV16/18 or high viral loads. Multivariable analyses showed HPV viral load and childbearing history were the independent factors affecting the accuracy of colposcopy (P < 0.05). Conclusion Colposcopy in HR-HPV-positive cytology-negative patients has a moderate diagnostic accuracy. The type of cervical transformation zone and HPV viral load are independent factors affecting the accuracy of colposcopy-based diagnosis.Keywords
Funding Information
- National Natural Science Foundation of China (81860515)
- Applied Basic Research Joint Special Fund Project of Yunnan Provincial Science and Technology Department-Kunming Medical University (2018FE001, -055)
- Yunnan Ten Thousand Youth Talent Program ([2018]73)
- yunnan ten thousand famous doctors special project ([2019]35)
- medical discipline leader in health commission of yunnan province (D-2019004)
This publication has 33 references indexed in Scilit:
- Triage of HPV positive women in cervical cancer screeningJournal of Clinical Virology, 2016
- Factors That Virtually Exclude Cervical Cancer at ColposcopyJournal of Lower Genital Tract Disease, 2015
- Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidanceGynecologic Oncology, 2015
- A Study of Genotyping for Management of Human Papillomavirus-Positive, Cytology-Negative Cervical Screening ResultsJournal of Clinical Microbiology, 2015
- The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening roundsHealth Technology Assessment, 2014
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trialsThe Lancet, 2014
- Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-PositiveJournal of Lower Genital Tract Disease, 2013
- Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA studyThe Lancet Oncology, 2011
- Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practiceThe Lancet Oncology, 2011
- Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort studyBMJ, 2008